Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Japanese Journal of Clinical Oncology|March 24, 2022
The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance studyYuichiro Ohe, Naoya Yamazaki, Nobuyuki Yamamoto, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2019
Improved survival among patients enrolled in oncology phase 1 trials in recent decadesTakahiro Ebata, Toshio Shimizu, Takafumi Koyama, et al.
The Prostate|November 24, 2024
Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation TherapyYoshinori Yanai, Takeo Kosaka, Shuji Mikami, et al.
Scientific Reports|November 19, 2021
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancerYoshinori Yanai, Takeo Kosaka, Shuji Mikami, et al.
Cancer Science|September 20, 2018
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumabShiro Kimbara, Yutaka Fujiwara, Shintaro Iwama, et al.
Oncogene|February 21, 2024
The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PKHiroki Sato, Tatsuo Ito, Takuo Hayashi, et al.
Journal of Neuro-Oncology|October 25, 2022
Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomasMakoto Ohno, Shigehisa Kitano, Kaishi Satomi, et al.
Oncoimmunology|July 9, 2024
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodesKazumi Okamura, Lifang Wang, Satoshi Nagayama, et al.
Frontiers in Oncology|October 19, 2020
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case ReportDaiki Ikarashi, Shigehisa Kitano, Kazuyuki Ishida, et al.
Japanese Journal of Clinical Oncology|June 11, 2021
Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study)Naoya Yamazaki, Tatsuya Takenouchi, Yasuhiro Nakamura, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Japanese Journal of Clinical Oncology|March 24, 2022
The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance studyYuichiro Ohe, Naoya Yamazaki, Nobuyuki Yamamoto, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2019
Improved survival among patients enrolled in oncology phase 1 trials in recent decadesTakahiro Ebata, Toshio Shimizu, Takafumi Koyama, et al.
The Prostate|November 24, 2024
Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation TherapyYoshinori Yanai, Takeo Kosaka, Shuji Mikami, et al.
Scientific Reports|November 19, 2021
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancerYoshinori Yanai, Takeo Kosaka, Shuji Mikami, et al.
Cancer Science|September 20, 2018
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumabShiro Kimbara, Yutaka Fujiwara, Shintaro Iwama, et al.
Oncogene|February 21, 2024
The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PKHiroki Sato, Tatsuo Ito, Takuo Hayashi, et al.
Journal of Neuro-Oncology|October 25, 2022
Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomasMakoto Ohno, Shigehisa Kitano, Kaishi Satomi, et al.
Oncoimmunology|July 9, 2024
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodesKazumi Okamura, Lifang Wang, Satoshi Nagayama, et al.
Frontiers in Oncology|October 19, 2020
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case ReportDaiki Ikarashi, Shigehisa Kitano, Kazuyuki Ishida, et al.
Japanese Journal of Clinical Oncology|June 11, 2021
Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study)Naoya Yamazaki, Tatsuya Takenouchi, Yasuhiro Nakamura, et al.
Pageof 15